STAT3 and hepatocellular carcinoma: Additionally, HDAC3 inhibitors exhibit antiviral effects by altering histone acetylation levels of significant transcription factors such as hypoxia‐inducible factor‐1 alpha (HIF‐1α) and STAT3, leading to their evaluation in clinical treatment for HCC [119].